Muhammad Ali et al. BTS 2016;1:

Slides:

Advertisements

Similar presentations

From: Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation Invest. Ophthalmol. Vis. Sci ;55(10):

Advertisements

TIA-1 Self-Multimerization, Phase Separation, and Recruitment into Stress Granules Are Dynamically Regulated by Zn2+ Joseph B. Rayman, Kevin A. Karl,

Cycloheximide inhibits arsenite‐induced stress granule formation and prevents the decreased number of senescent cells mediated by repeated arsenite treatment.

SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.

Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.

Treatment with BLU9931 leads to tumor regression in the FGF19-overexpressing PDX-derived xenograft LIXC012. Treatment with BLU9931 leads to tumor regression.

Rodney H. Falk et al. JACC 2016;68:

Effects of senescent cells on activity.

18F-FDG uptake is a noninvasive biomarker of combined MEK–mTORC1 inhibition. 18F-FDG uptake is a noninvasive biomarker of combined MEK–mTORC1 inhibition.

Volume 127, Issue 2, Pages (August 2004)

Isaac Perea-Gil et al. BTS 2016;1:

Hui-Fang Song et al. BTS 2017;2:

Fig. 5. Pharmacological JAK2 inhibition in vivo abrogates tumor-initiating potential after chemotherapy. Pharmacological JAK2 inhibition in vivo abrogates.

Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.

Volume 24, Issue 7, Pages (March 2014)

Treatment with BLU9931 leads to tumor regression in the FGF19-amplified Hep 3B liver cancer model. Treatment with BLU9931 leads to tumor regression in.

Stefano Toldo et al. BTS 2017;2:

Jason A. Bartos et al. BTS 2016;j.jacbts

Combination of OTX‐015 and PD does not induce overt toxicity

Nikole J. Byrne et al. BTS 2017;j.jacbts

Dandan Wang et al. BTS 2018;3: Overexpression of miR-24 Ameliorates Diabetic Ischemia/Reperfusion Injury (A) Schematic protocol of miR-24 delivery.

Dandan Wang et al. BTS 2018;3: Diabetes Exacerbates Myocardial Infarction and Ischemia/Reperfusion Injury (A) Comparison of fasting blood glucose.

Henry Chubb et al. JACEP 2017;3:89-103

Hironori Hara et al. BTS 2018;3:

Jessica L. Ungerleider et al. BTS 2016;1:32-44

Masanobu Ishii et al. BTS 2017;2:

Volume 19, Issue 1, Pages (April 2017)

Mohamed A. Saleh et al. BTS 2016;1:

Helena M. Viola et al. BTS 2018;3:

TIA-1 Self-Multimerization, Phase Separation, and Recruitment into Stress Granules Are Dynamically Regulated by Zn2+ Joseph B. Rayman, Kevin A. Karl,

AS aggregates interact with SERCA in SH‐SY5Y cells

Volume 17, Issue 5, Pages (October 2016)

Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial.

Volume 19, Issue 1, Pages (April 2017)

In vivo silencing of Factor VII in liver hepatocytes.

Pharmacologic inhibition of eIF5A hypusination sensitizes KRas-driven tumor cells to MEK and KRas inhibition. Pharmacologic inhibition of eIF5A hypusination.

Coregulation of VGAT and cGMP levels by dopamine.

Nikole J. Byrne et al. BTS 2017;j.jacbts

Fig. 4. CIZ1 reduces the impact of injury to the heart.

Oral administration of CX-4945 suppresses Tau phosphorylation in DYRK1A-overexpressing mice. Oral administration of CX-4945 suppresses Tau phosphorylation.

Liver AMPK is activated by oral administration of canagliflozin in mice, but this does not explain changes in RER. A: Phosphorylation of AMPK, ACC, and.

Pie charts (for all the mice together) and bar graph (for individual mouse) showing relative percentage of T cells and B cells present in the Raman spectroscopy–investigated.

A: Chemical structure of pterosin A

CO-1686 does not inhibit WT EGFR signaling in vivo and is active in EGFR-mutant transgenic mouse lung cancer models. CO-1686 does not inhibit WT EGFR signaling.

Pioglitazone administration acutely inhibits insulin secretion and increases insulin clearance in Wistar rats. Pioglitazone administration acutely inhibits.

Fig. 4 Administration of BMS to mice inhibits autoimmune-relevant pharmacodynamic endpoints driven by IL-12 and IFNα. Administration of BMS

Ju Youn Beak et al. BTS 2017;2:39-53

Treatment with CN-105 significantly decreased microgliosis associated with brain injury after SAH. Images of immunostained brain slices with F4/80 for.

NSG mice transplanted with human primary ALK-positive ALCL tumor grafts were administered either doxorubicin, 10 mg/kg i.v. or CEP orally, 100 mg/kg,

Effects of DPM treatment on tumor volume, tumor mass, and pulmonary metastasis at experimental end point. Effects of DPM treatment on tumor volume, tumor.

The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.

CD25 expression predicts effector and memory differentiation.

Michael A. Makara et al. BTS 2018;3:

The antitumor and antimetastatic properties of PF in the MX1 orthotopic model. The antitumor and antimetastatic properties of PF in the.

Pharmacological targeting of CDs promotes response to KRASG12C inhibition in vivo. Pharmacological targeting of CDs promotes response to KRASG12C inhibition.

Ketogenic diets combined with fractionated radiation treatment results in decreased immunoreactive PCNA in tumor tissue. Ketogenic diets combined with.

LAIV enhances bacterial load and duration of staphylococcal carriage.

MEP amplitude ratios for pre- and post-A-tDCS of the ABA-6HRS control group. MEP amplitude ratios for pre- and post-A-tDCS of the ABA-6HRS control group.

MEP amplitude ratios for pre- and post-A-tDCS.

CRA inhibits the growth of human tumor xenografts in vivo.

NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.

HMQ1611 inhibited breast tumor growth in mice.

Subodh Verma et al. BTS 2018;3:

Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.

TAE-684 effectively inhibits the growth of H3122 in vivo.

PDL192 and inhibit the growth of xenograft tumors.

Ganetespib suppresses tumor growth and extends survival in ALK+ NSCLC xenografts. Ganetespib suppresses tumor growth and extends survival in ALK+ NSCLC.

Volume 25, Issue 4, Pages (April 2017)

In vivo effect of KIN-193 on PTEN-deficient tumors.

Fig. 3 MCA-mediated neutrophil recruitment accelerates bacterial clearance in the skin. MCA-mediated neutrophil recruitment accelerates bacterial clearance.

Presentation transcript:

Muhammad Ali et al. BTS 2016;1:633-643 Day 2 MPO Inhibition With PF-1355 (A) Mice with permanent coronary ligation were administered with oral 50 mg/kg PF-1355 (2-[6-(2,5-dimethoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl]acetamide) twice daily and compared with vehicle-treated control animals (n = 4 to 7 per group). On day 2 post–myocardial infarction (MI), hearts were processed for extracellular protein fractions (ECF), intracellular protein fractions (ICF), and myeloperoxidase (MPO) activity was performed with antibody capture assay with 10-acetyl-3,7-dihydroxyphenoxazine, reported as relative fluorescence units (RFU)/s/μg of protein. (B to D) In vivo MPO inhibition as measured by bis-5-hydroxytryptamide-diethylenetriaminepentaacetate-gadolinium imaging. (B) Representative T1-weighted midventricular slices showing pre-contrast, early (15 min), and delayed (60 min) contrast-enhanced images; dotted areas represent the infarct areas. (C) Lesion activation ratio (LAR) of untreated (n = 4) and PF-1355–treated groups (n = 15); bar graphs represent 60-min CNR values. (D) CNR values plotted as a function of time show a decrease in enhancement over time compared with untreated control subjects. (E) There is no significant difference in infarct area between groups at day 2 post-MI. Data plotted as mean ± SEM; *p < 0.05; **p < 0.01; ∗∗∗p < 0.001. Muhammad Ali et al. BTS 2016;1:633-643 The Authors